Interrogating the phosphoproteome for targets and markers in pancreatic cancer Pancreatic cancer (PDAC) is a highly lethal and chemoresistant disease. The failure of (targeted) therapies can be attributed to the strong inter- and intra-tumor heterogeneity in terms of complexity of genetic aberrations and the resulting signaling pathway activities, as well as to resistance mechanisms that quickly adapt the […]
Read MoreKWF grant on PDAC phosphoproteomics awarded
- January 19, 2017
- Comments off